2007
DOI: 10.1016/j.bios.2006.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Dehydrogenase based reagentless biosensor for monitoring phenylketonuria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
38
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(38 citation statements)
references
References 26 publications
0
38
0
Order By: Relevance
“…In the work reported here, the FEED technique was applied to the enzyme-linked amperometric immuno-sensing scheme and the feasibility of using this new detection approach as a biomarker detection technique was demonstrated by the detection of the biomarker CA 125, using electrodes modified with carbon nanotube. The incorporation of the two detection methods has resulted in a reagentless assay approach (Wang, 2005;Weiss et al, 2007), another advantage of the reported technique, which does not use electron transfer mediators and the substrate of the enzyme used to label the secondary antibody. As the result of the signal amplification, the detection limit of the detection system was lowered from 4.9 U/ml to 0.9 U/ml.…”
Section: Introductionmentioning
confidence: 99%
“…In the work reported here, the FEED technique was applied to the enzyme-linked amperometric immuno-sensing scheme and the feasibility of using this new detection approach as a biomarker detection technique was demonstrated by the detection of the biomarker CA 125, using electrodes modified with carbon nanotube. The incorporation of the two detection methods has resulted in a reagentless assay approach (Wang, 2005;Weiss et al, 2007), another advantage of the reported technique, which does not use electron transfer mediators and the substrate of the enzyme used to label the secondary antibody. As the result of the signal amplification, the detection limit of the detection system was lowered from 4.9 U/ml to 0.9 U/ml.…”
Section: Introductionmentioning
confidence: 99%
“…Weiss and coworkers prepared and characterized the first reagentless dehydrogenase based biosensor for monitoring Phe levels in human urine with a Phe detection limit of 0.5 mM [2]. More recently, a PKU screening method based on gas chromatography-mass spectrometry (GC-MS) and tandem mass spectrometry (MS-MS) was developed.…”
Section: Introductionmentioning
confidence: 98%
“…The main symptom of PKU is the accumulation of Phe in blood, urine, and cerebrospinal fluid. The clinical ranges of Phe for patients in human blood and urine are 0.6~3.8 and 20~60 mM, respectively [2].…”
Section: Introductionmentioning
confidence: 99%
“…In order to increase its stability and economical application, special attention is currently devoted on the modification and the immobilization of L-PheDH. For instance, L-PheDH immobilization on tresylated poly(vinyl alcohol) beads [16], modification with cyclodextrin derivatives [17], biosensor coated amino-activated cellulose membrane by cross-linking with glutaraldehyde (GDA) [18], L-adamantanyl modified L-PheDH immobilization on β-cyclodextrins coated Au electrode [19], and carbon paste electrode with 3,4-dihydroxybenzaldehyde as an electron mediator [20] can be given as examples to the limited research in this area.…”
Section: Introductionmentioning
confidence: 99%